Chimeric Antigen Receptor T-cell Therapy
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Chimeric Antigen Receptor T-cell Therapy, covering 2025-07-28 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: Outcomes After Chimeric Antigen Receptor Therapy and Radiation Therapy for Hematologic Malignancies